Renal Cell Carcinoma
Filters
Topics
Recommended Topics
Renal Cell Carcinoma Diagnosis Early Stage Renal Cell Carcinoma Advanced Stage Renal Cell Carcinoma Adjuvant Immunotherapy for Early Stage Renal Cell Carcinoma Localized Non-Surgical Therapy for Early Stage Renal Cell Carcinoma Targeted Therapies for Advanced Stage Renal Cell Carcinoma PD-1 Immunotherapy for Advanced Stage Renal Cell Carcinoma Interferon Immunotherapy for Advanced Stage Renal Cell Carcinoma IL2 Immunotherapy for Advanced Stage Renal Cell Carcinoma Surgery Indications in Renal Cell CarcinomaAll Topics
Adjuvant Immunotherapy for Early Stage Renal Cell Carcinoma Advanced Stage Renal Cell Carcinoma Early Stage Renal Cell Carcinoma IL2 Immunotherapy for Advanced Stage Renal Cell Carcinoma Interferon Immunotherapy for Advanced Stage Renal Cell Carcinoma Localized Non-Surgical Therapy for Early Stage Renal Cell Carcinoma PD-1 Immunotherapy for Advanced Stage Renal Cell Carcinoma Renal Cell Carcinoma Diagnosis Surgery Indications in Renal Cell Carcinoma Targeted Therapies for Advanced Stage Renal Cell CarcinomaAll Videos
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Summary: Biomarkers in RCC - Current State and Future Potential
FEATURING
Simpa Salami
- 75 views
- February 26, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Summary: Adjuvant Therapy in RCC - A Practical Guide
FEATURING
Laurence Albiges
- 34 views
- February 24, 2025
Insights from 2025 ASCO® GU Annual Meeting
ASCO® GU 2025 Insights: Cabozantinib + Nivo + Ipi in 1L aRCC - Final Results of COSMIC-313
FEATURING
Laurence Albiges
- 30 views
- February 20, 2025
- 1
Society of Laparoscopic & Robotic Surgeons
Robotic Single-Port Donor Nephrectomy for Multiple Renal Arteries
FEATURING
Michael Palese
- 24 views
- February 3, 2025
COR2ED The Heart of Medical Education
New Directions in Systemic Therapy for Non-Clear Cell RCC
FEATURING
Laurence Albiges
- 36 views
- January 27, 2025
Leonardo Reis
Year in Review: Advances in Kidney Cancer Ablation: Current Uses and Emerging Techniques
- 235 views
- January 8, 2025
- 3
Yale Cancer Center
Tolerability of TKIs in aRCC Beyond 2L: Treatment Selection and Patient Evaluation
FEATURING
Renee Maria Saliby
- 35 views
- December 19, 2024
Ketan Badani
Year in Review: Cutting Edge Advances in Kidney Cancer - Imaging and Minimally Invasive Treatments
- 463 views
- December 19, 2024
- 3
Oncology 2024 Year in Review
Year in Review 2024 - 1L Combination Therapies for aRCC
FEATURING
Yousef Zakharia
- 234 views
- December 16, 2024
- 1
Jason Hafron
Year in Review: Kidney Cancer - 2024 Insights and Exciting Prospects in 2025
- 95 views
- December 16, 2024
- 1
International Urology Cancer Summit - IUCS
External Validation of the Meet-URO Score in mRCC on 1L Immuno-Combination Therapy
FEATURING
Aruni Ghose
- 33 views
- December 9, 2024
Pavlos Msaouel
Sitravatinib + Nivo/Ipi in Advanced RCC: Outcomes and Translational Correlatives
- 55 views
- December 6, 2024
- 1
Oncology 2024 Year in Review
Year in Review 2024 - Renal Cell Carcinoma
FEATURING
Nataliya Mar
- 301 views
- December 2, 2024
Miguel Ramos
SIU 2024 Insights: Partial Nephrectomy - Open, Laparoscopic or Robotic?
- 158 views
- November 6, 2024
- 2
International Urology Cancer Summit - IUCS
Liquid vs. Tumor Biopsy in Urological Tumors
FEATURING
Christian Rolfo
- 31 views
- November 4, 2024
COR2ED The Heart of Medical Education
ESMO 2024 Summary: Key Trial Updates on IO and Targeted Treatments in GU Cancers
FEATURING
Ray Manneh Kopp
- 90 views
- November 4, 2024
- 1
Camillo Porta
TIVO-3 Trial: Evaluating Tivozanib as a Targeted Therapy for Advanced RCC
- 136 views
- October 31, 2024
- 1
Camillo Porta
Tivozanib + Nivo vs. Tivozanib Monotherapy in RCC: TiNivo-2 Results
- 157 views
- October 30, 2024
- 1
The View on GU | with Lalani & Wallis
Review of Kidney Cancer Updates From ESMO 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 39 views
- October 30, 2024
International Urology Cancer Summit - IUCS
Updating Treatment Sequencing for mRCC
FEATURING
Naveen Vasudev
- 175 views
- October 28, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Developmental Therapeutics Highlights
FEATURING
Guru Sonpavde
- 326 views
- October 25, 2024
- 4
International Urology Cancer Summit - IUCS
Treatment (De)Intensification in RCC
FEATURING
Sumanta Kumar Pal
- 288 views
- October 23, 2024
- 4
ecancer
ESMO 2024 Summary: Highlights & Analysis of the Biggest Solid Cancer Updates
FEATURING
Bishal Gyawali
- 49 views
- October 21, 2024
ecancer
ESMO 2024 Insights: SUNNIFORECAST Trial - Nivo + Ipi vs. Standard of Care in Non-Clear-Cell RCCs
FEATURING
Lothar Bergmann
- 12 views
- October 16, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Novel Agents and Promising Combinations in mRCC and mUC
FEATURING
Begoña Pérez-Valderrama
- 128 views
- October 8, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Patient and Tumor Selection for Retroperitoneal Partial Nephrectomy
FEATURING
Craig Rogers
- 19 views
- October 4, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Retroperitoneal Surgery Return to Uro Space: Tips for Port Placement
FEATURING
Jennifer Linehan
- 47 views
- October 4, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
SP Partial Nephrectomy
FEATURING
Ryan Nelson
- 29 views
- October 4, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Retroperitoneal Surgery Return to Uro Space: Steps of Retro RPN
FEATURING
Jennifer Linehan
- 160 views
- October 4, 2024
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Retroperitoneal RPN - Installing the Intuitive SP Access Port, Procedure & Outcome
FEATURING
Ryan Nelson
- 162 views
- October 4, 2024
- 1
Michigan Urological Surgery Improvement Collaborative (MUSIC)
Trouble Shooting - Multiport Tips for Retro RPN
FEATURING
Jennifer Linehan
- 228 views
- October 4, 2024
- 1
Dana-Farber Cancer Institute
No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Phase 3 Results for mRCC
FEATURING
Bradley McGregor
- 276 views
- October 3, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC), and CheckMate 9ER (aRCC)
FEATURING
Camillo Porta
- 238 views
- October 2, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: ORACLE Study - Outcomes With Novel Combination Therapies in Non-Clear Cell RCC
FEATURING
Deepak Kilari
- 16 views
- October 1, 2024
COR2ED The Heart of Medical Education
Advanced RCC: Managing Long Term Durable Response
FEATURING
Michael Staehler
- 29 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: SC vs. IV Nivolumab in Advanced/Metastatic RCC - Ph3 CheckMate 67T
FEATURING
Laurence Albiges
- 125 views
- September 19, 2024
- 1
Martin Zarba
Multidisciplinary Approaches to Systemic and Local Therapies in mRCC
- 84 views
- September 14, 2024
- 1
The View on GU | with Lalani & Wallis
Review of Kidney Cancer Updates From ASCO® 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 31 views
- September 6, 2024
The View on GU | with Lalani & Wallis
Review of GU Cancer Takeaways From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 56 views
- September 5, 2024
The View on GU | with Lalani & Wallis
Review of Kidney Cancer Updates From ASCO® GU 2024
FEATURING
Aly-Khan A. Lalani,
Christopher Wallis
- 26 views
- September 5, 2024
Yale Cancer Center
Molecular Markers of Microscopic Disease in RCC
FEATURING
David Braun
- 32 views
- September 4, 2024
Yale Cancer Center
Harnessing the Immune System to Treat Kidney Cancer
FEATURING
David Braun,
Eric Winer
- 13 views
- September 4, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Key RCC/Bladder/Testicular GU Updates From ASCO® 2024
FEATURING
Jonathan Trujillo
- 61 views
- September 4, 2024
- 1
Renee Maria Saliby
Emerging Novel Functional Imaging and Advances in Immunotherapy in RCC
- 76 views
- August 28, 2024
University of Miami Sylvester Comprehensive Cancer Center
Advances and Precision Medicine in Bladder and Kidney Cancer
FEATURING
Jaime Merchan
- 44 views
- August 20, 2024
Taylor Goodstein
Optimizing First-Line Doublet Therapy in mRCC for Special Populations
- 44 views
- August 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications for the Practicing Oncologist"
FEATURING
Kriti Mittal
- 388 views
- July 16, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Bladder and RCC Highlights"
FEATURING
Karine Tawagi,
Natalie Reizine
- 269 views
- July 16, 2024
- 4
Memorial Sloan Kettering Cancer Center
Clinical Perspectives on Managing Hereditary Kidney Cancer
FEATURING
Jonathan Coleman
- 55 views
- July 9, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO in RCC"
FEATURING
Talal El Zarif
- 254 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CA-62 - A New Biomarker for the Detection of Early Stage RCC"
FEATURING
Evgueni Klinski
- 30 views
- June 11, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - Belzutifan in Advanced ccRCC"
FEATURING
Michael Atkins
- 102 views
- June 10, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"
FEATURING
Eric Jonasch
- 219 views
- June 5, 2024
David McDermott
Overview of a SoC in 1L mRCC Focusing on the Long-Term Survival Data
- 275 views
- May 10, 2024
University of Illinois Cancer Center
Recent Advances in Molecular-Guided Treatment of GU Malignancies
FEATURING
Natalie Reizine
- 271 views
- May 10, 2024
- 2
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Type I IFN Response in Brain Metastasis
FEATURING
Qingrong Chen
- 77 views
- April 30, 2024
- 1
Oncology Data Advisor
Kidney Cancer Awareness Month: Spotlight on Genetic Counseling
FEATURING
Hiam Abdel-Salam,
Donika Saporito
- 14 views
- April 26, 2024
Yale Cancer Center
Insights Into Kidney Cancer: Diagnosis, Treatment, and Genetic Components
FEATURING
Michael Hurwitz
- 65 views
- April 19, 2024
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
FEATURING
Young Chae
- 1,246 views
- April 19, 2024
- 5
Yale Cancer Center
Microenvironmental Determinants of Systemic Therapy Response in Kidney Cancer: From Human to Mouse and Back
FEATURING
Ari Hakimi
- 15 views
- April 18, 2024
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 2,230 views
- April 16, 2024
- 12
Northwestern Medicine Oncology and Hematology
HRQoL Data in aRCC: The Importance of Assessment and Impact on Clinical Outcomes
FEATURING
David Cella
- 112 views
- April 15, 2024
Insights from 2024 ASCO® GU Annual Meeting
The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors
FEATURING
Rana McKay
- 190 views
- April 15, 2024
- 2
Dana-Farber Cancer Institute
RCC Highlights From ASCO® GU 2024
FEATURING
Wenxin Xu,
Toni Choueiri
- 338 views
- March 14, 2024
- 5
Insights from 2024 ASCO® GU Annual Meeting
Recent GU Developments and Their Clinical Implications
FEATURING
Thomas Powles,
Brian Rini
- 1,542 views
- March 7, 2024
- 6
University of Colorado Department of Medicine
Cardiotoxicity in RCC – Case Discussion
FEATURING
Lavanya Kondapalli
- 85 views
- March 7, 2024
Total Health
Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024
FEATURING
Melissa Reimers
- 535 views
- March 5, 2024
- 1
OncoAlert
Urology Year in Review: Prostate Cancer Screening, EMBARK Trial, PSMA PET, Opera Trial, and Adjuvant Therapies
FEATURING
Axel Merseburger
- 176 views
- February 20, 2024
OncoAlert
Best of GU Radiation Oncology From ASTRO 2023
FEATURING
Sophia Kamran
- 51 views
- February 20, 2024
OncoAlert
Year in Review: RCC Practice Changing and Practice Informing Trials Updates
FEATURING
Toni Choueiri
- 280 views
- February 20, 2024
- 1
OncoAlert
Treating Genitourinary Cancers With Limited Resources
FEATURING
Yüksel Ürün
- 53 views
- February 20, 2024
- 1
Yale Cancer Center
The Importance of Yearly Check-Ups for Men and Screening for Urologic Cancers
FEATURING
Michael Karellas
- 59 views
- February 13, 2024
- 1
ecancer
ASCO® GU 2024 Insights: "CLEAR Trial - Lenvatinib & Pembrolizumab in 1L Treatment of aRCC"
FEATURING
Viktor Grünwald
- 50 views
- February 13, 2024
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Insights: "Update on Biomarkers in Renal Cell Carcinoma"
FEATURING
David Braun
- 133 views
- February 9, 2024
- 2
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Management of Non-ccRCC"
FEATURING
Katy Beckermann
- 88 views
- February 8, 2024
ImmunoTherapy Bridge 2023
Best of SITC 2023 for Clinical Development and IO Trials
FEATURING
Paolo A. Ascierto
- 94 views
- January 11, 2024
- 1
ImmunoTherapy Bridge 2023
IO Combinations in aRCC: New Achievements and Challenges
FEATURING
Roberto Iacovelli
- 51 views
- January 9, 2024
Dana-Farber Cancer Institute
Kidney Cancer Highlights From ESMO 2023
FEATURING
Wenxin Xu,
Toni Choueiri
- 176 views
- December 11, 2023
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "MEDI5752 (Volrustomig) in the 1L Treatment of Patients With Advanced ccRCC"
FEATURING
Martin Voss
- 132 views
- November 24, 2023
UNC Lineberger Comprehensive Cancer Center
UNC Kidney Cancer Management Updates
FEATURING
Hung-Jui Tan
- 221 views
- November 20, 2023
[PRIVATE] Scripps MD Anderson Cancer Center
Recent Advances in Therapy for Renal Cancer
FEATURING
Munveer Bhangoo
- 116 views
- November 7, 2023
- 1
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of RCC"
FEATURING
Guillermo de Velasco
- 319 views
- November 3, 2023
- 4
ecancer
ESMO 2023 Insights: "Results From Phase 2 LITESPARK-003 Study - Belzutifan+Cabozantinib Combination for Advanced ccRCC"
FEATURING
Toni Choueiri
- 78 views
- October 25, 2023
ecancer
ESMO 2023 Insights: "Comparing Belzutifan With Everolimus in Pretreated Advanced Clear Cell RCC - Results From LITESPARK-005 Study"
FEATURING
Toni Choueiri
- 72 views
- October 25, 2023
International Urology Cancer Summit - IUCS
Today Biomarkers and Targets in GU Cancers
FEATURING
Pasquale Rescigno
- 233 views
- October 24, 2023
International Urology Cancer Summit - IUCS
Are Prognostic Scores Useful for Adjuvant and Palliative Therapy in mRCC?
FEATURING
Sara Rebuzzi
- 56 views
- October 24, 2023
International Urology Cancer Summit - IUCS
Debate on Immunotherapy in Adjuvant RCC and UC – PROs
FEATURING
Yüksel Ürün
- 108 views
- October 24, 2023
International Urology Cancer Summit - IUCS
Debate on Immunotherapy in Adjuvant RCC and UC – CONs
FEATURING
Richard Griffiths
- 172 views
- October 24, 2023
International Urology Cancer Summit - IUCS
When Surgery Should Be Offered in mRCC
FEATURING
Jeremy Teoh
- 61 views
- October 23, 2023
International Urology Cancer Summit - IUCS
How to Choose 1L Therapy for mRCC
FEATURING
Monty Pal
- 245 views
- October 23, 2023
- 3
The France Foundation
Immune Checkpoint Inhibitors & RCC: Where Are We Now?
- 237 views
- October 20, 2023
- 1
